International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones.
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Appleton, WI
Ascension St. Elizabeth Hospital
Chilton, WI
Ascension Calumet Hospital
Escanaba, MI
OSF St. Francis Hospital
Green Bay – East, WI
HSHS St. Vincent Hospital
Green Bay – West, WI
HSHS St. Mary’s Hospital Medical Center
Manistique, MI
Schoolcraft Memorial Hospital
Oconto Falls, WI
HSHS St. Clare Memorial Hospital
Oshkosh, WI
Ascension Mercy Hospital
Sheboygan, WI
HSHS St. Nicholas Hospital
Sturgeon Bay, WI
Door County Medical Center
Copyright © 2024 All Rights Reserved